Clinical trial
Erlotinib in Treating Patients With Locally Advanced and/or Metastatic…
NCT00030485 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00030485 |
|---|---|
| Title | Erlotinib in Treating Patients With Locally Advanced and/or Metastatic Endometrial Cancer |
| Official title | A Phase II Study of OSI-774 (NSC 718781) in Patients With Locally Advanced and/or Metastatic Carcinoma of the Endometrium |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Collaborators | NCIC Clinical Trials Group |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Endometrial Cancer |
| Intervention type | Drug |
| Interventions | erlotinib hydrochloride |
| Start date | Jan 1, 2002 |
| Primary completion | Apr 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Jan 27, 2014 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: